Art. 106a Directive (EU) 2001/83

In forcesince 20 Jan 2011cited 13×
1.

As soon as the marketing authorisation holder intends to make a public announcement relating to information on pharmacovigilance concerns in relation to the use of a medicinal product, and in any event at the same time or before the public announcement is made, he shall be required to inform the national competent authorities, the Agency and the Commission.

The marketing authorisation holder shall ensure that information to the public is presented objectively and is not misleading.

2.

Unless urgent public announcements are required for the protection of public health, the Member States, the Agency and the Commission shall inform each other not less than 24 hours prior to a public announcement relating to information on pharmacovigilance concerns.

3.

For active substances contained in medicinal products authorised in more than one Member State, the Agency shall be responsible for the coordination between national competent authorities of safety announcements and shall provide timetables for the information being made public.

Under the coordination of the Agency, the Member States shall make all reasonable efforts to agree on a common message in relation to the safety of the medicinal product concerned and the timetables for their distribution. The Pharmacovigilance Risk Assessment Committee shall, at the request of the Agency, provide advice on those safety announcements.

4.

When the Agency or national competent authorities make public information referred to in paragraphs 2 and 3, any information of a personal or commercially confidential nature shall be deleted unless its public disclosure is necessary for the protection of public health.

The 10 that are cited most themselves, of 13.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…22Law

    … soient pas trompeuses et d’en informer l’Agence, conformément à l’article 22 du présent règlement et à l’article 106 bis, paragraphe 1, de la directive 2001/83/CE. 18. L’obligation de respecter les délais pour le …

  • Regulation (EU) No 1235/2010 of the European Parliament and of the Council of 15 Decembe…1Law

    … artikel 9, stk. 4, litra ca). De forpligtelser, der påhviler indehaveren af en markedsføringstilladelse, jf. artikel 106a, stk. 1, i direktiv 2001/83/EF, og medlemsstaternes, agenturets og Kommissionens forpligtelser, jf. stk. 2, 3 og 4 …

  • Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…1Law

    … artikel 22 i forordning (EF) nr. 726/2004, sammenholdt med artikel 106a, stk. 1, i direktiv 2001/83/EF 24. forpligtelsen til at overholde fristerne for påbegyndelse eller afslutning af de foranstaltninger, der er anført i agenturets …

  • Commission Regulation (EU) No 488/2012 of 8 June 2012 amending Regulation (EC) No 658/20…1Law

    … artikel 22 i forordning (EF) nr. 726/2004, sammenholdt med artikel 106a, stk. 1, i direktiv 2001/83/EF 24. forpligtelsen til at overholde fristerne for påbegyndelse eller afslutning af de foranstaltninger, der er anført i agenturets …

  • Regulation (EU) 2019/5Law

    … nærværende forordnings artikel 22 og artikel 106a, stk. 1, i direktiv 2001/83/EF 18) forpligtelsen til at overholde fristerne for påbegyndelse eller afslutning af de foranstaltninger, der er anført i agenturets afgørelse om …

  • Commission Implementing Regulation (EU) No 520/2012 of 19 June 2012 on the performance o…15Law

    … v několika členských státech nebo účinné látky obsažené v daném léčivém přípravku v souladu s článkem 106a směrnice 2001/83/ES; f) provádět inspekce a předregistrační inspekce. 2. Kromě postupů uvedených v …

  • Commission Regulation (EU) No 488/2012 of 8 June 2012 amending Regulation (EC) No 658/20…1Law

    … and to notify them to the Agency, as provided for in Article 22 of Regulation (EC) No 726/2004 read together with Article 106a(1) of Directive 2001/83/EC; the obligation to comply with the time limits for initiating or completing measures …

  • Judgment of the Court (Grand Chamber) of 23 January 2018. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del MerDecision

    Moreover, the conditions for dissemination of information on medicinal products to healthcare professionals and the general public are governed, in particular, by Article 106a of amended Directive 2001/83, which applies to the holder of an …

    23 Jan 2018 · 62016CJ0179

  • Opinion of Advocate General Saugmandsgaard Øe delivered on 21 September 2017. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della CDecision

    … ligeledes, hvad angår de af medlemsstaterne godkendte lægemidler, artikel 106a, stk. 1, andet afsnit, i direktiv 2001/83.].

    21 Sep 2017 · 62016CC0179

  • Commission Regulation (EC) No 658/2007 of 14 June 2007 concerning financial penalties fo…1Law

    … and to notify them to the Agency, as provided for in Article 22 of Regulation (EC) No 726/2004 read together with Article 106a(1) of Directive 2001/83/EC; the obligation to comply with the time limits for initiating or completing measures …